+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anti Tumour Necrosis Factor"

Psoriasis Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030 - Product Thumbnail Image

Psoriasis Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030

  • Report
  • August 2022
  • 118 Pages
  • Global
From
Tumor Necrosis Factor (TNF) Inhibitors MarkeSize, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029 - Product Thumbnail Image

Tumor Necrosis Factor (TNF) Inhibitors MarkeSize, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029

  • Report
  • September 2021
  • 111 Pages
  • Global
From
Global Tumor Necrosis Factor (TNF) Inhibitors Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026 - Product Thumbnail Image

Global Tumor Necrosis Factor (TNF) Inhibitors Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026

  • Report
  • April 2018
  • Global
From
Psoriatic Arthritis Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031 - Product Thumbnail Image

Psoriatic Arthritis Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031

  • Report
  • January 2023
  • 116 Pages
  • Global
From
Investigation Report on China's Infliximab Market 2022-2031 - Product Thumbnail Image

Investigation Report on China's Infliximab Market 2022-2031

  • Report
  • July 2022
  • 40 Pages
  • China
From
Father of Humira, Greg Winter, Wins 2018 Nobel Prize For Chemistry - Product Thumbnail Image

Father of Humira, Greg Winter, Wins 2018 Nobel Prize For Chemistry

  • Newsletter
  • May 2024
  • 2 Pages
  • Global
From
Datamonitor Healthcare Strategy: Immuno-Oncology Deal Trends, 2014-18 - Product Thumbnail Image

Datamonitor Healthcare Strategy: Immuno-Oncology Deal Trends, 2014-18

  • Report
  • August 2019
  • 42 Pages
  • Global
Rituxan - Product Thumbnail Image

Rituxan

  • Report
  • January 2019
  • 82 Pages
  • Global
From
Alofisel - Product Thumbnail Image

Alofisel

  • Report
  • August 2018
  • 21 Pages
  • Global
From
Simponi - Product Thumbnail Image

Simponi

  • Report
  • May 2018
  • 55 Pages
  • Global
From
Global Autoimmune Drugs Market 2023-2027 - Product Thumbnail Image

Global Autoimmune Drugs Market 2023-2027

  • Report
  • January 2023
  • 173 Pages
  • Global
From
Global Anti-inflammatory Therapeutics Market 2023-2027 - Product Thumbnail Image

Global Anti-inflammatory Therapeutics Market 2023-2027

  • Report
  • December 2022
  • 120 Pages
  • Global
From
Ulcerative Colitis Epidemiology Analysis and Forecast, 2021-2031 - Product Thumbnail Image

Ulcerative Colitis Epidemiology Analysis and Forecast, 2021-2031

  • Report
  • February 2023
  • 48 Pages
  • Global
From
Crohn's Disease - Global Drug Forecast and Market Analysis to 2029 - Product Thumbnail Image

Crohn's Disease - Global Drug Forecast and Market Analysis to 2029

  • Report
  • September 2020
  • 148 Pages
  • Global
From
Psoriatic Arthritis: Global Drug Forecast and Market Analysis to 2028 - Product Thumbnail Image

Psoriatic Arthritis: Global Drug Forecast and Market Analysis to 2028

  • Report
  • January 2020
  • 130 Pages
  • Global
From
Axial Spondyloarthritis: Global Drug Forecast and Market Analysis to 2028 - Product Thumbnail Image

Axial Spondyloarthritis: Global Drug Forecast and Market Analysis to 2028

  • Report
  • October 2019
  • 128 Pages
  • Global
From
Systemic Lupus Erythematosus: Programs Targeting Cytokine and Growth Factor Signaling Dominate First-in-Class Pipeline - Product Thumbnail Image

Systemic Lupus Erythematosus: Programs Targeting Cytokine and Growth Factor Signaling Dominate First-in-Class Pipeline

  • Report
  • June 2019
  • 53 Pages
  • Global
From
Gastrointestinal Disorders: Innovative Pipeline Offers Potential for First Approved Therapies in NASH and Celiac Disease - Product Thumbnail Image

Gastrointestinal Disorders: Innovative Pipeline Offers Potential for First Approved Therapies in NASH and Celiac Disease

  • Report
  • March 2019
  • 165 Pages
  • Global
From
KOL Perspectives: Treatment strategies for pregnant RA patients - Product Thumbnail Image

KOL Perspectives: Treatment strategies for pregnant RA patients

  • Drug Pipelines
  • July 2018
  • 27 Pages
  • Global
From
Axial Spondyloarthritis (AxSpA): Competitive Landscape to 2026 - Product Thumbnail Image

Axial Spondyloarthritis (AxSpA): Competitive Landscape to 2026

  • Report
  • June 2018
  • 52 Pages
  • Global
From
Loading Indicator

The Anti Tumour Necrosis Factor (anti-TNF) market is a subset of the Immune Disorders Drugs market. Anti-TNF drugs are used to treat a variety of immune-mediated diseases, such as rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. These drugs work by blocking the action of TNF, a protein that is involved in inflammation and tissue destruction. Anti-TNF drugs are generally administered as injections or infusions, and are often used in combination with other medications. The anti-TNF market is highly competitive, with a number of companies offering products. These include AbbVie, Amgen, Janssen, Merck, Pfizer, and UCB. Each company has its own portfolio of anti-TNF drugs, and they are continually developing new products to meet the needs of patients. Show Less Read more